Review




Structured Review

Korean Cell Line Bank hct15 cells
Hct15 Cells, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hct15+cells/cells+hct15/pm41857570-71-8-17
Average 86 stars, based on 1 article reviews
hct15 cells - by Bioz Stars, 2026-10
86/100 stars

Images

Related Articles

Knockdown:

Article Title: 6,8-Diprenylorobol induces apoptosis in human colon cancer cells via activation of intracellular reactive oxygen species and p53.
Article Snippet: Department of Bio and Chemical Engineering, Hongik University, Sejong, South Korea Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, South Korea Division of Biotechnology, Jeonbuk National University, Iksan, South Korea Department of Biological Science, Gachon University, Seongnam, South Korea Department of Biological Engineering, Konkuk University, Seoul, South Korea Department of Biomedical Sciences, Seoul National University, Graduate School, Seoul, South Korea Department of Medicine, College of Medicine, Seoul National University, Seoul, South Korea Department of Pathology, Jeonbuk National University Medical School, Jeonju, South Korea Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju, South Korea Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, South Korea

Expressing:

Article Title: 6,8-Diprenylorobol induces apoptosis in human colon cancer cells via activation of intracellular reactive oxygen species and p53.
Article Snippet: Department of Bio and Chemical Engineering, Hongik University, Sejong, South Korea Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, South Korea Division of Biotechnology, Jeonbuk National University, Iksan, South Korea Department of Biological Science, Gachon University, Seongnam, South Korea Department of Biological Engineering, Konkuk University, Seoul, South Korea Department of Biomedical Sciences, Seoul National University, Graduate School, Seoul, South Korea Department of Medicine, College of Medicine, Seoul National University, Seoul, South Korea Department of Pathology, Jeonbuk National University Medical School, Jeonju, South Korea Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju, South Korea Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, South Korea

Western Blot:

Article Title: 6,8-Diprenylorobol induces apoptosis in human colon cancer cells via activation of intracellular reactive oxygen species and p53.
Article Snippet: Department of Bio and Chemical Engineering, Hongik University, Sejong, South Korea Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, South Korea Division of Biotechnology, Jeonbuk National University, Iksan, South Korea Department of Biological Science, Gachon University, Seongnam, South Korea Department of Biological Engineering, Konkuk University, Seoul, South Korea Department of Biomedical Sciences, Seoul National University, Graduate School, Seoul, South Korea Department of Medicine, College of Medicine, Seoul National University, Seoul, South Korea Department of Pathology, Jeonbuk National University Medical School, Jeonju, South Korea Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju, South Korea Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, South Korea

Quantitative RT-PCR:

Article Title: 6,8-Diprenylorobol induces apoptosis in human colon cancer cells via activation of intracellular reactive oxygen species and p53.
Article Snippet: Department of Bio and Chemical Engineering, Hongik University, Sejong, South Korea Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, South Korea Division of Biotechnology, Jeonbuk National University, Iksan, South Korea Department of Biological Science, Gachon University, Seongnam, South Korea Department of Biological Engineering, Konkuk University, Seoul, South Korea Department of Biomedical Sciences, Seoul National University, Graduate School, Seoul, South Korea Department of Medicine, College of Medicine, Seoul National University, Seoul, South Korea Department of Pathology, Jeonbuk National University Medical School, Jeonju, South Korea Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju, South Korea Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, South Korea

Control:

Article Title: 6,8-Diprenylorobol induces apoptosis in human colon cancer cells via activation of intracellular reactive oxygen species and p53.
Article Snippet: Department of Bio and Chemical Engineering, Hongik University, Sejong, South Korea Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, South Korea Division of Biotechnology, Jeonbuk National University, Iksan, South Korea Department of Biological Science, Gachon University, Seongnam, South Korea Department of Biological Engineering, Konkuk University, Seoul, South Korea Department of Biomedical Sciences, Seoul National University, Graduate School, Seoul, South Korea Department of Medicine, College of Medicine, Seoul National University, Seoul, South Korea Department of Pathology, Jeonbuk National University Medical School, Jeonju, South Korea Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju, South Korea Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, South Korea

Transfection:

Article Title: 6,8-Diprenylorobol induces apoptosis in human colon cancer cells via activation of intracellular reactive oxygen species and p53.
Article Snippet: Department of Bio and Chemical Engineering, Hongik University, Sejong, South Korea Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, South Korea Division of Biotechnology, Jeonbuk National University, Iksan, South Korea Department of Biological Science, Gachon University, Seongnam, South Korea Department of Biological Engineering, Konkuk University, Seoul, South Korea Department of Biomedical Sciences, Seoul National University, Graduate School, Seoul, South Korea Department of Medicine, College of Medicine, Seoul National University, Seoul, South Korea Department of Pathology, Jeonbuk National University Medical School, Jeonju, South Korea Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju, South Korea Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, South Korea

CCK-8 Assay:

Article Title: 6,8-Diprenylorobol induces apoptosis in human colon cancer cells via activation of intracellular reactive oxygen species and p53.
Article Snippet: Department of Bio and Chemical Engineering, Hongik University, Sejong, South Korea Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, South Korea Division of Biotechnology, Jeonbuk National University, Iksan, South Korea Department of Biological Science, Gachon University, Seongnam, South Korea Department of Biological Engineering, Konkuk University, Seoul, South Korea Department of Biomedical Sciences, Seoul National University, Graduate School, Seoul, South Korea Department of Medicine, College of Medicine, Seoul National University, Seoul, South Korea Department of Pathology, Jeonbuk National University Medical School, Jeonju, South Korea Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju, South Korea Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, South Korea

Incubation:

Article Title: 6,8-Diprenylorobol induces apoptosis in human colon cancer cells via activation of intracellular reactive oxygen species and p53.
Article Snippet: Department of Bio and Chemical Engineering, Hongik University, Sejong, South Korea Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, South Korea Division of Biotechnology, Jeonbuk National University, Iksan, South Korea Department of Biological Science, Gachon University, Seongnam, South Korea Department of Biological Engineering, Konkuk University, Seoul, South Korea Department of Biomedical Sciences, Seoul National University, Graduate School, Seoul, South Korea Department of Medicine, College of Medicine, Seoul National University, Seoul, South Korea Department of Pathology, Jeonbuk National University Medical School, Jeonju, South Korea Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju, South Korea Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, South Korea

Staining:

Article Title: 6,8-Diprenylorobol induces apoptosis in human colon cancer cells via activation of intracellular reactive oxygen species and p53.
Article Snippet: Department of Bio and Chemical Engineering, Hongik University, Sejong, South Korea Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, South Korea Division of Biotechnology, Jeonbuk National University, Iksan, South Korea Department of Biological Science, Gachon University, Seongnam, South Korea Department of Biological Engineering, Konkuk University, Seoul, South Korea Department of Biomedical Sciences, Seoul National University, Graduate School, Seoul, South Korea Department of Medicine, College of Medicine, Seoul National University, Seoul, South Korea Department of Pathology, Jeonbuk National University Medical School, Jeonju, South Korea Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju, South Korea Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, South Korea

Diff-Quik:

Article Title: 6,8-Diprenylorobol induces apoptosis in human colon cancer cells via activation of intracellular reactive oxygen species and p53.
Article Snippet: Department of Bio and Chemical Engineering, Hongik University, Sejong, South Korea Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, South Korea Division of Biotechnology, Jeonbuk National University, Iksan, South Korea Department of Biological Science, Gachon University, Seongnam, South Korea Department of Biological Engineering, Konkuk University, Seoul, South Korea Department of Biomedical Sciences, Seoul National University, Graduate School, Seoul, South Korea Department of Medicine, College of Medicine, Seoul National University, Seoul, South Korea Department of Pathology, Jeonbuk National University Medical School, Jeonju, South Korea Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju, South Korea Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, South Korea

Extraction:

Article Title: 6,8-Diprenylorobol induces apoptosis in human colon cancer cells via activation of intracellular reactive oxygen species and p53.
Article Snippet: Department of Bio and Chemical Engineering, Hongik University, Sejong, South Korea Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, South Korea Division of Biotechnology, Jeonbuk National University, Iksan, South Korea Department of Biological Science, Gachon University, Seongnam, South Korea Department of Biological Engineering, Konkuk University, Seoul, South Korea Department of Biomedical Sciences, Seoul National University, Graduate School, Seoul, South Korea Department of Medicine, College of Medicine, Seoul National University, Seoul, South Korea Department of Pathology, Jeonbuk National University Medical School, Jeonju, South Korea Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju, South Korea Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, South Korea

Cell Culture:

Article Title: 6,8-Diprenylorobol induces apoptosis in human colon cancer cells via activation of intracellular reactive oxygen species and p53.
Article Snippet: Department of Bio and Chemical Engineering, Hongik University, Sejong, South Korea Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, South Korea Division of Biotechnology, Jeonbuk National University, Iksan, South Korea Department of Biological Science, Gachon University, Seongnam, South Korea Department of Biological Engineering, Konkuk University, Seoul, South Korea Department of Biomedical Sciences, Seoul National University, Graduate School, Seoul, South Korea Department of Medicine, College of Medicine, Seoul National University, Seoul, South Korea Department of Pathology, Jeonbuk National University Medical School, Jeonju, South Korea Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju, South Korea Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, South Korea

Purification:

Article Title: 6,8-Diprenylorobol induces apoptosis in human colon cancer cells via activation of intracellular reactive oxygen species and p53.
Article Snippet: Department of Bio and Chemical Engineering, Hongik University, Sejong, South Korea Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, South Korea Division of Biotechnology, Jeonbuk National University, Iksan, South Korea Department of Biological Science, Gachon University, Seongnam, South Korea Department of Biological Engineering, Konkuk University, Seoul, South Korea Department of Biomedical Sciences, Seoul National University, Graduate School, Seoul, South Korea Department of Medicine, College of Medicine, Seoul National University, Seoul, South Korea Department of Pathology, Jeonbuk National University Medical School, Jeonju, South Korea Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju, South Korea Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, South Korea

Phospho-proteomics:

Article Title: 6,8-Diprenylorobol induces apoptosis in human colon cancer cells via activation of intracellular reactive oxygen species and p53.
Article Snippet: Department of Bio and Chemical Engineering, Hongik University, Sejong, South Korea Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, South Korea Division of Biotechnology, Jeonbuk National University, Iksan, South Korea Department of Biological Science, Gachon University, Seongnam, South Korea Department of Biological Engineering, Konkuk University, Seoul, South Korea Department of Biomedical Sciences, Seoul National University, Graduate School, Seoul, South Korea Department of Medicine, College of Medicine, Seoul National University, Seoul, South Korea Department of Pathology, Jeonbuk National University Medical School, Jeonju, South Korea Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju, South Korea Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, South Korea

Alternative Splicing:

Article Title: 6,8-Diprenylorobol induces apoptosis in human colon cancer cells via activation of intracellular reactive oxygen species and p53.
Article Snippet: Department of Bio and Chemical Engineering, Hongik University, Sejong, South Korea Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, South Korea Division of Biotechnology, Jeonbuk National University, Iksan, South Korea Department of Biological Science, Gachon University, Seongnam, South Korea Department of Biological Engineering, Konkuk University, Seoul, South Korea Department of Biomedical Sciences, Seoul National University, Graduate School, Seoul, South Korea Department of Medicine, College of Medicine, Seoul National University, Seoul, South Korea Department of Pathology, Jeonbuk National University Medical School, Jeonju, South Korea Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju, South Korea Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, South Korea

Produced:

Article Title: 6,8-Diprenylorobol induces apoptosis in human colon cancer cells via activation of intracellular reactive oxygen species and p53.
Article Snippet: Department of Bio and Chemical Engineering, Hongik University, Sejong, South Korea Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, South Korea Division of Biotechnology, Jeonbuk National University, Iksan, South Korea Department of Biological Science, Gachon University, Seongnam, South Korea Department of Biological Engineering, Konkuk University, Seoul, South Korea Department of Biomedical Sciences, Seoul National University, Graduate School, Seoul, South Korea Department of Medicine, College of Medicine, Seoul National University, Seoul, South Korea Department of Pathology, Jeonbuk National University Medical School, Jeonju, South Korea Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju, South Korea Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, South Korea

Fluorescence:

Article Title: 6,8-Diprenylorobol induces apoptosis in human colon cancer cells via activation of intracellular reactive oxygen species and p53.
Article Snippet: Department of Bio and Chemical Engineering, Hongik University, Sejong, South Korea Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, South Korea Division of Biotechnology, Jeonbuk National University, Iksan, South Korea Department of Biological Science, Gachon University, Seongnam, South Korea Department of Biological Engineering, Konkuk University, Seoul, South Korea Department of Biomedical Sciences, Seoul National University, Graduate School, Seoul, South Korea Department of Medicine, College of Medicine, Seoul National University, Seoul, South Korea Department of Pathology, Jeonbuk National University Medical School, Jeonju, South Korea Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju, South Korea Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, South Korea

Reverse Transcription Polymerase Chain Reaction:

Article Title: 6,8-Diprenylorobol induces apoptosis in human colon cancer cells via activation of intracellular reactive oxygen species and p53.
Article Snippet: Department of Bio and Chemical Engineering, Hongik University, Sejong, South Korea Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, South Korea Division of Biotechnology, Jeonbuk National University, Iksan, South Korea Department of Biological Science, Gachon University, Seongnam, South Korea Department of Biological Engineering, Konkuk University, Seoul, South Korea Department of Biomedical Sciences, Seoul National University, Graduate School, Seoul, South Korea Department of Medicine, College of Medicine, Seoul National University, Seoul, South Korea Department of Pathology, Jeonbuk National University Medical School, Jeonju, South Korea Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju, South Korea Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, South Korea

Activation Assay:

Article Title: 6,8-Diprenylorobol induces apoptosis in human colon cancer cells via activation of intracellular reactive oxygen species and p53.
Article Snippet: Department of Bio and Chemical Engineering, Hongik University, Sejong, South Korea Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, South Korea Division of Biotechnology, Jeonbuk National University, Iksan, South Korea Department of Biological Science, Gachon University, Seongnam, South Korea Department of Biological Engineering, Konkuk University, Seoul, South Korea Department of Biomedical Sciences, Seoul National University, Graduate School, Seoul, South Korea Department of Medicine, College of Medicine, Seoul National University, Seoul, South Korea Department of Pathology, Jeonbuk National University Medical School, Jeonju, South Korea Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju, South Korea Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, South Korea

Negative Control:

Article Title: 6,8-Diprenylorobol induces apoptosis in human colon cancer cells via activation of intracellular reactive oxygen species and p53.
Article Snippet: Department of Bio and Chemical Engineering, Hongik University, Sejong, South Korea Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, South Korea Division of Biotechnology, Jeonbuk National University, Iksan, South Korea Department of Biological Science, Gachon University, Seongnam, South Korea Department of Biological Engineering, Konkuk University, Seoul, South Korea Department of Biomedical Sciences, Seoul National University, Graduate School, Seoul, South Korea Department of Medicine, College of Medicine, Seoul National University, Seoul, South Korea Department of Pathology, Jeonbuk National University Medical School, Jeonju, South Korea Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju, South Korea Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, South Korea



Similar Products

97
ATCC hct15 cells
Hct15 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hct15+cells/HCT-15/pm42178241-18-55-54
Average 97 stars, based on 1 article reviews
hct15 cells - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier

97
ATCC colorectal adenocarcinoma cell line hct15
Colorectal Adenocarcinoma Cell Line Hct15, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hct15+cells/HCT-15/pm42014751-103-2-11
Average 97 stars, based on 1 article reviews
colorectal adenocarcinoma cell line hct15 - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier

97
ATCC colorectal cancer cell lines hct15
Urolithin A suppresses CRC cell proliferation and enhances T-cell activation. (A) Dose–response curves of UA in <t>HCT15,</t> HCT116, MC38, NCM460 and MCEC cells at 48 h and 72 h, with corresponding IC 50 values. The selectivity index (SI = IC 50 normal / IC 50 cancer) is shown for each cell line; (B-C) Effects of increasing concentrations of UA on the viability of CTLL-2 cells and human CD8 + T cells (hCD8 + T) at 48 h; (D) Schematic illustration of T-cell and tumor cell co-culture in the presence of UA; (E-G) Cell viability assays demonstrating that combined treatment with UA (20 or 25 µM) and T cells more effectively suppresses the proliferation of HCT15, HCT116, and MC38 cells compared with UA or T-cell treatment alone; (H) Western blot analysis showing the effects of UA (15, 20 or 25 µM) on the phosphorylation levels of AKT and mTOR in HCT15, HCT116, and MC38 cells, as well as the regulation of p-FOXO1, TCF1, GZMB, and p-AKT in hCD8⁺ T cells and CTLL-2 cells. P < 0.05 was considered statistically significant (* P < 0.05, ** P < 0.01, *** P < 0.001).
Colorectal Cancer Cell Lines Hct15, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hct15+cells/HCT-15/pmc13184318-17-3-44
Average 97 stars, based on 1 article reviews
colorectal cancer cell lines hct15 - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier

86
Korean Cell Line Bank hct15 cells
Urolithin A suppresses CRC cell proliferation and enhances T-cell activation. (A) Dose–response curves of UA in <t>HCT15,</t> HCT116, MC38, NCM460 and MCEC cells at 48 h and 72 h, with corresponding IC 50 values. The selectivity index (SI = IC 50 normal / IC 50 cancer) is shown for each cell line; (B-C) Effects of increasing concentrations of UA on the viability of CTLL-2 cells and human CD8 + T cells (hCD8 + T) at 48 h; (D) Schematic illustration of T-cell and tumor cell co-culture in the presence of UA; (E-G) Cell viability assays demonstrating that combined treatment with UA (20 or 25 µM) and T cells more effectively suppresses the proliferation of HCT15, HCT116, and MC38 cells compared with UA or T-cell treatment alone; (H) Western blot analysis showing the effects of UA (15, 20 or 25 µM) on the phosphorylation levels of AKT and mTOR in HCT15, HCT116, and MC38 cells, as well as the regulation of p-FOXO1, TCF1, GZMB, and p-AKT in hCD8⁺ T cells and CTLL-2 cells. P < 0.05 was considered statistically significant (* P < 0.05, ** P < 0.01, *** P < 0.001).
Hct15 Cells, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hct15+cells/cells+hct15/pm41857570-71-8-17
Average 86 stars, based on 1 article reviews
hct15 cells - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

94
ATCC human colorectal cancer cell lines
Urolithin A suppresses CRC cell proliferation and enhances T-cell activation. (A) Dose–response curves of UA in <t>HCT15,</t> HCT116, MC38, NCM460 and MCEC cells at 48 h and 72 h, with corresponding IC 50 values. The selectivity index (SI = IC 50 normal / IC 50 cancer) is shown for each cell line; (B-C) Effects of increasing concentrations of UA on the viability of CTLL-2 cells and human CD8 + T cells (hCD8 + T) at 48 h; (D) Schematic illustration of T-cell and tumor cell co-culture in the presence of UA; (E-G) Cell viability assays demonstrating that combined treatment with UA (20 or 25 µM) and T cells more effectively suppresses the proliferation of HCT15, HCT116, and MC38 cells compared with UA or T-cell treatment alone; (H) Western blot analysis showing the effects of UA (15, 20 or 25 µM) on the phosphorylation levels of AKT and mTOR in HCT15, HCT116, and MC38 cells, as well as the regulation of p-FOXO1, TCF1, GZMB, and p-AKT in hCD8⁺ T cells and CTLL-2 cells. P < 0.05 was considered statistically significant (* P < 0.05, ** P < 0.01, *** P < 0.001).
Human Colorectal Cancer Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hct15+cells/HCT-15%3B+Colorectal+Carcinoma%3B+Human/pm41750281-60-1-6
Average 94 stars, based on 1 article reviews
human colorectal cancer cell lines - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

86
Eurofins hct15 colorectal cancer cell lines
Urolithin A suppresses CRC cell proliferation and enhances T-cell activation. (A) Dose–response curves of UA in <t>HCT15,</t> HCT116, MC38, NCM460 and MCEC cells at 48 h and 72 h, with corresponding IC 50 values. The selectivity index (SI = IC 50 normal / IC 50 cancer) is shown for each cell line; (B-C) Effects of increasing concentrations of UA on the viability of CTLL-2 cells and human CD8 + T cells (hCD8 + T) at 48 h; (D) Schematic illustration of T-cell and tumor cell co-culture in the presence of UA; (E-G) Cell viability assays demonstrating that combined treatment with UA (20 or 25 µM) and T cells more effectively suppresses the proliferation of HCT15, HCT116, and MC38 cells compared with UA or T-cell treatment alone; (H) Western blot analysis showing the effects of UA (15, 20 or 25 µM) on the phosphorylation levels of AKT and mTOR in HCT15, HCT116, and MC38 cells, as well as the regulation of p-FOXO1, TCF1, GZMB, and p-AKT in hCD8⁺ T cells and CTLL-2 cells. P < 0.05 was considered statistically significant (* P < 0.05, ** P < 0.01, *** P < 0.001).
Hct15 Colorectal Cancer Cell Lines, supplied by Eurofins, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hct15+cells/cell+lines/pm41681975-197-4-13
Average 86 stars, based on 1 article reviews
hct15 colorectal cancer cell lines - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

Image Search Results


Urolithin A suppresses CRC cell proliferation and enhances T-cell activation. (A) Dose–response curves of UA in HCT15, HCT116, MC38, NCM460 and MCEC cells at 48 h and 72 h, with corresponding IC 50 values. The selectivity index (SI = IC 50 normal / IC 50 cancer) is shown for each cell line; (B-C) Effects of increasing concentrations of UA on the viability of CTLL-2 cells and human CD8 + T cells (hCD8 + T) at 48 h; (D) Schematic illustration of T-cell and tumor cell co-culture in the presence of UA; (E-G) Cell viability assays demonstrating that combined treatment with UA (20 or 25 µM) and T cells more effectively suppresses the proliferation of HCT15, HCT116, and MC38 cells compared with UA or T-cell treatment alone; (H) Western blot analysis showing the effects of UA (15, 20 or 25 µM) on the phosphorylation levels of AKT and mTOR in HCT15, HCT116, and MC38 cells, as well as the regulation of p-FOXO1, TCF1, GZMB, and p-AKT in hCD8⁺ T cells and CTLL-2 cells. P < 0.05 was considered statistically significant (* P < 0.05, ** P < 0.01, *** P < 0.001).

Journal: Scientific Reports

Article Title: Urolithin A blocks colorectal cancer progression by AKT1 inhibition–driven immune activation

doi: 10.1038/s41598-026-45621-y

Figure Lengend Snippet: Urolithin A suppresses CRC cell proliferation and enhances T-cell activation. (A) Dose–response curves of UA in HCT15, HCT116, MC38, NCM460 and MCEC cells at 48 h and 72 h, with corresponding IC 50 values. The selectivity index (SI = IC 50 normal / IC 50 cancer) is shown for each cell line; (B-C) Effects of increasing concentrations of UA on the viability of CTLL-2 cells and human CD8 + T cells (hCD8 + T) at 48 h; (D) Schematic illustration of T-cell and tumor cell co-culture in the presence of UA; (E-G) Cell viability assays demonstrating that combined treatment with UA (20 or 25 µM) and T cells more effectively suppresses the proliferation of HCT15, HCT116, and MC38 cells compared with UA or T-cell treatment alone; (H) Western blot analysis showing the effects of UA (15, 20 or 25 µM) on the phosphorylation levels of AKT and mTOR in HCT15, HCT116, and MC38 cells, as well as the regulation of p-FOXO1, TCF1, GZMB, and p-AKT in hCD8⁺ T cells and CTLL-2 cells. P < 0.05 was considered statistically significant (* P < 0.05, ** P < 0.01, *** P < 0.001).

Article Snippet: Cell lines The colorectal cancer cell lines HCT15, HCT116, and MC38; the colonic epithelial cell line NCM460; and the human and murine lymphocyte cell lines CTLL-2 were obtained from Procell (Wuhan, China), while the murine colonic epithelial cell line MCEC was purchased from the ATCC cell bank.

Techniques: Activation Assay, Co-Culture Assay, Western Blot, Phospho-proteomics

Urolithin A suppresses CRC proliferation, migration, invasion, and enhances CD8⁺ T-cell infiltration. (A–B) Wound-healing assays and quantification showing that UA(20 μm) combined with lymphocytes (hCD8 + T cells or CTLL-2) markedly inhibits migration of HCT15, HCT116, and MC38 cells at 24 h and 48 h; (C–D) Transwell invasion and migration assays and quantification indicating that UA (20 μm) together with lymphocytes significantly reduces invasion index of HCT15, HCT116, and MC38 cells; (E)Schematic diagram of the MC38 orthotopic colorectal cancer mouse model and treatment regimen with UA (100 mg/kg/day); (F–G) Representative macroscopic images and tumor volume measurements demonstrating that UA treatment inhibits tumor growth; (H) Representative H&E staining of tumors from vehicle- and UA-treated mice; (I) Immunohistochemical staining of Ki67 showing decreased proliferation in UA-treated tumors; (J) Immunohistochemical staining of CD8 revealing enhanced CD8⁺ T-cell infiltration in UA-treated tumors; (K) Quantitative analysis showing that UA lowers the proliferation index and increases CD8⁺ T-cell infiltration in vivo . P < 0.05 was considered statistically significant (* P < 0.05, ** P < 0.01, *** P < 0.001).

Journal: Scientific Reports

Article Title: Urolithin A blocks colorectal cancer progression by AKT1 inhibition–driven immune activation

doi: 10.1038/s41598-026-45621-y

Figure Lengend Snippet: Urolithin A suppresses CRC proliferation, migration, invasion, and enhances CD8⁺ T-cell infiltration. (A–B) Wound-healing assays and quantification showing that UA(20 μm) combined with lymphocytes (hCD8 + T cells or CTLL-2) markedly inhibits migration of HCT15, HCT116, and MC38 cells at 24 h and 48 h; (C–D) Transwell invasion and migration assays and quantification indicating that UA (20 μm) together with lymphocytes significantly reduces invasion index of HCT15, HCT116, and MC38 cells; (E)Schematic diagram of the MC38 orthotopic colorectal cancer mouse model and treatment regimen with UA (100 mg/kg/day); (F–G) Representative macroscopic images and tumor volume measurements demonstrating that UA treatment inhibits tumor growth; (H) Representative H&E staining of tumors from vehicle- and UA-treated mice; (I) Immunohistochemical staining of Ki67 showing decreased proliferation in UA-treated tumors; (J) Immunohistochemical staining of CD8 revealing enhanced CD8⁺ T-cell infiltration in UA-treated tumors; (K) Quantitative analysis showing that UA lowers the proliferation index and increases CD8⁺ T-cell infiltration in vivo . P < 0.05 was considered statistically significant (* P < 0.05, ** P < 0.01, *** P < 0.001).

Article Snippet: Cell lines The colorectal cancer cell lines HCT15, HCT116, and MC38; the colonic epithelial cell line NCM460; and the human and murine lymphocyte cell lines CTLL-2 were obtained from Procell (Wuhan, China), while the murine colonic epithelial cell line MCEC was purchased from the ATCC cell bank.

Techniques: Migration, Staining, Immunohistochemical staining, In Vivo